Cite
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
MLA
Lucero, Olivia M., et al. “Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 20, Oct. 2023, pp. 4230–41. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-22-0906.
APA
Lucero, O. M., Lee, J.-A., Bowman, J., Johnson, K., Sapparapu, G., Thomas, J. K., Fan, G., Chang, B. H., Thiel-Klare, K., Eide, C. A., Okada, C., Palazzolo, M., Lind, E., Kosaka, Y., Druker, B. J., Lydon, N., & Bowers, P. M. (2023). Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 29(20), 4230–4241. https://doi.org/10.1158/1078-0432.CCR-22-0906
Chicago
Lucero, Olivia M, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu, John K Thomas, Guang Fan, et al. 2023. “Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29 (20): 4230–41. doi:10.1158/1078-0432.CCR-22-0906.